DexCom (DXCM) Revenue — Quarter Ended Sep 30, 2025
Revenue increased for the quarter, continuing the positive trend from the prior period and showing higher growth compared to the same period a year ago.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue increased for the quarter, continuing the positive trend from the prior period and showing higher growth compared to the same period a year ago.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.2B
Revenue reported for this quarter.
Quarter-over-quarter
+4.5%
Change from the immediately preceding quarter.
Year-over-year
+21.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $1.1B | +7.6% |
| Mar 31, 2025 | $1B | +12.5% |
| Jun 30, 2025 | $1.2B | +15.2% |
| Sep 30, 2025 | $1.2B | +21.6% |
Revenue performance
The reported revenue rose, reflecting continued expansion from the immediately preceding quarter.
Quarterly comparison
Compared to the immediately preceding quarter, revenue improved. Versus the same quarter one year earlier, revenue also increased, with a larger gain than the sequential change.
What to watch
Future revenue performance will depend on the company's ability to scale operations and meet product demand globally.